SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 344.18 |
| Enterprise Value ($M) | 301.30 |
| Book Value ($M) | 78.95 |
| Book Value / Share | 2.32 |
| Price / Book | 4.36 |
| NCAV ($M) | 4.07 |
| NCAV / Share | 0.12 |
| Price / NCAV | 84.57 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.76 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -0.87 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.22 |
| Current Ratio | 5.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 229.63 |
| Assets | 304.51 |
| Liabilities | 225.56 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 11.80 | 17.94 | |
| 13G/A | Fmr Llc | 2.42 | -51.75 | |
| 13G/A | Invus Global Management, LLC | 9.90 | ||
| 13D/A | Baker Bros. Advisors Lp | 12.40 | 10.71 | |
| 13G/A | Artal International S.C.A. | 9.40 | 26.55 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 44,619 | 183,775 | 24.28 | |
| 65,089 | 276,369 | 23.55 | |
| 29,385 | 154,239 | 19.05 | |
| 68,691 | 370,137 | 18.56 | |
| 165,313 | 531,949 | 31.08 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IDXX – IDEXX Laboratories, Inc. | IDYA – IDEAYA Biosciences, Inc. |
| IFRX – InflaRx N.V. | IMUX – Immunic, Inc. |
| IMVT – Immunovant, Inc. |
Financial data and stock pages provided by
Fintel.io